JPS5945679B2 - Captoganillectin and its isolation and purification method - Google Patents
Captoganillectin and its isolation and purification methodInfo
- Publication number
- JPS5945679B2 JPS5945679B2 JP634077A JP634077A JPS5945679B2 JP S5945679 B2 JPS5945679 B2 JP S5945679B2 JP 634077 A JP634077 A JP 634077A JP 634077 A JP634077 A JP 634077A JP S5945679 B2 JPS5945679 B2 JP S5945679B2
- Authority
- JP
- Japan
- Prior art keywords
- lectin
- affinity
- horseshoe crab
- acetylamino
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 7
- 238000002955 isolation Methods 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
- 102000004856 Lectins Human genes 0.000 claims description 33
- 108090001090 Lectins Proteins 0.000 claims description 33
- 239000002523 lectin Substances 0.000 claims description 33
- 235000000346 sugar Nutrition 0.000 claims description 15
- 241000239224 Tachypleus tridentatus Species 0.000 claims description 13
- -1 N-acetylamino sugars Chemical class 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 8
- 238000001042 affinity chromatography Methods 0.000 claims description 7
- 239000003446 ligand Substances 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 5
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 101150069554 HIS4 gene Proteins 0.000 claims 1
- 101001018097 Homo sapiens L-selectin Proteins 0.000 claims 1
- 102100033467 L-selectin Human genes 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 210000003743 erythrocyte Anatomy 0.000 description 10
- 230000004520 agglutination Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 5
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 5
- 210000000087 hemolymph Anatomy 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 241001529572 Chaceon affinis Species 0.000 description 4
- 241000283073 Equus caballus Species 0.000 description 4
- 241000239205 Merostomata Species 0.000 description 4
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 4
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 4
- 229950006780 n-acetylglucosamine Drugs 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 102000015728 Mucins Human genes 0.000 description 3
- 108010063954 Mucins Proteins 0.000 description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 3
- OVRNDRQMDRJTHS-OZRXBMAMSA-N N-acetyl-beta-D-mannosamine Chemical compound CC(=O)N[C@@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-OZRXBMAMSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000035931 haemagglutination Effects 0.000 description 3
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 3
- 210000001913 submandibular gland Anatomy 0.000 description 3
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- 102000002068 Glycopeptides Human genes 0.000 description 2
- 108010015899 Glycopeptides Proteins 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 2
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 2
- FDJKUWYYUZCUJX-UHFFFAOYSA-N N-glycolyl-beta-neuraminic acid Natural products OCC(O)C(O)C1OC(O)(C(O)=O)CC(O)C1NC(=O)CO FDJKUWYYUZCUJX-UHFFFAOYSA-N 0.000 description 2
- 102000005348 Neuraminidase Human genes 0.000 description 2
- 108010006232 Neuraminidase Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000012847 fine chemical Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 241000239218 Limulus Species 0.000 description 1
- OVRNDRQMDRJTHS-ZTVVOAFPSA-N N-acetyl-D-mannosamine Chemical compound CC(=O)N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-ZTVVOAFPSA-N 0.000 description 1
- FDJKUWYYUZCUJX-AJKRCSPLSA-N N-glycoloyl-beta-neuraminic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@@H]1O[C@](O)(C(O)=O)C[C@H](O)[C@H]1NC(=O)CO FDJKUWYYUZCUJX-AJKRCSPLSA-N 0.000 description 1
- SUHQNCLNRUAGOO-UHFFFAOYSA-N N-glycoloyl-neuraminic acid Natural products OCC(O)C(O)C(O)C(NC(=O)CO)C(O)CC(=O)C(O)=O SUHQNCLNRUAGOO-UHFFFAOYSA-N 0.000 description 1
- FDJKUWYYUZCUJX-KVNVFURPSA-N N-glycolylneuraminic acid Chemical compound OC[C@H](O)[C@H](O)[C@@H]1O[C@](O)(C(O)=O)C[C@H](O)[C@H]1NC(=O)CO FDJKUWYYUZCUJX-KVNVFURPSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 241000239222 Tachypleus Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Description
【発明の詳細な説明】
本発明は、日本産カブトガニ(Tachypleust
ridentatus)由来のレクチンに関するもので
あり、詳細には日本産カブトガニの血リンパ液を出発物
質としN−アセチルアミノ糖及び/またはN−アセチル
アミノ糖含有物質をリガントとするアフイニテイクロマ
トグラフイーを用いることを特徴とするN−アセチルア
ミノ糖に広い親和性を示すカブトガニレクチンの分離精
製法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to Japanese horseshoe crab (Tachypleust).
ridentatus), and specifically, using affinity chromatography using Japanese horseshoe crab hemolymph as a starting material and N-acetylamino sugar and/or N-acetylamino sugar-containing substance as a ligand. The present invention relates to a method for separating and purifying horseshoe crab lectin, which exhibits a wide affinity for N-acetylamino sugars.
レクチンは動植物、微生物由来の蛋白質で、赤血球に対
し特異的な結合を示す物質の総称であり、古くから植物
由来の赤血球凝集素が知られている。Lectin is a protein derived from animals, plants, and microorganisms, and is a general term for substances that bind specifically to red blood cells, and hemagglutinin, which is derived from plants, has been known for a long time.
この赤血球凝集反応は、レクチンが血球に存在する糖鎖
と、特異的に結合することにより起ると云われている。
又、或種のレクチンは、赤血球のみでなく、白血球、ガ
ン細胞等を特異的に凝集することが近年知られている。This hemagglutination reaction is said to occur when lectins specifically bind to sugar chains present on blood cells.
Furthermore, it has recently been known that certain lectins specifically aggregate not only red blood cells, but also white blood cells, cancer cells, and the like.
最近では植物ばかりでなく動物からも、レクチンが見い
出されており、その生理的意義や、活性について注目さ
れるところとなつて来た。本発明者らは、日本産カブト
ガニ(Tachyple一Ustridentatus
)の血リンパ液成分を検討している過程で、従来のレク
チンに見い出せない糖結合特異性を有するレクチンの存
在を見い出し、本発明に到達した。Recently, lectins have been discovered not only in plants but also in animals, and their physiological significance and activity have been attracting attention. The present inventors have discovered that the Japanese horseshoe crab (Tachyple-Ustridentatus)
), we discovered the existence of a lectin with sugar-binding specificity not found in conventional lectins, and arrived at the present invention.
カブトガニは生きた化石といわれ、古代からのまま、現
存する貴重な生物で、生息地も北米東海岸、アジア東沿
部に限定され、現在3属4種が知られている。Horseshoe crabs are said to be living fossils, and are valuable creatures that have existed since ancient times. Their habitat is limited to the east coast of North America and the eastern coast of Asia, and there are currently three genera and four species known.
日本産カブトガニJapaneseHOrseshOe
Crab(学名Tachypleustridsnta
tus)はわずかに瀬戸内海及び北九州に生息するのみ
で、北米産カブトガニAmericaHOrseshO
eCrab(学名LimulusPOlypheOSu
s)の血液成分、性質が検討されているのに反し、ほと
んどその生理的、化学的検討は行なわれていない。Japanese horseshoe crab JapaneseHOrseshOe
Crab (scientific name: Tachypleustridsnta)
tus) only inhabits the Seto Inland Sea and Kitakyushu, and is similar to the North American horseshoe crab AmericaHOrseshO.
eCrab (scientific name: Limulus POlypheOSu)
Although the blood components and properties of s) have been studied, almost no physiological or chemical studies have been conducted.
北米産カブトガニ血リンパ液中には、N−アセチルノイ
ラミン酸(NANへ)、N−グリコリルノイラミン酸(
NGNA)に親和性を有するレクチンの存在が知られて
おり、その化学的性質も報告されている{ROche,
A.C.,BBA.37l242(1974)}。The hemolymph of horseshoe crabs from North America contains N-acetylneuraminic acid (to NAN) and N-glycolylneuraminic acid (to NAN).
The existence of a lectin that has an affinity for NGNA) is known, and its chemical properties have also been reported {ROche,
A. C. , B.B.A. 37l242 (1974)}.
本発明者らは、この北米産カブトガニ由来のレクチンに
見られない性質を有する新規レクチンの存在を日本産カ
ブトガニの血リンパ液中に見い出しこれを分取精製した
。すなわち、日本産カブトガニ(Tachypleus
tridenta一Tus)の血り7パ液を、ウシ、ウ
マ、ヒツジ等の顎下腺ムチンや、キチン等のN−アセチ
ルアミノ糖含有物質をリガントとした、アガロース系ア
フイニテイクロマトグラフイ一用担体を用いて吸着分離
分画し、更務こその一画分をNANAsN−アセチルグ
ルコサミン(GlcNAc)、N−アセチルガラクトサ
ミン(Gl『NAc)、N−アセチルマンノサミン(M
anNAc)等のN−アセチルアミノ糖を結合リガント
としたアフイニテイクロマトグラフイ一用担体を用いて
精製し、これらN−アセチルアミノ糖に親和性を示すレ
クチンを得る。かくして得られる本発明のレクチンはL
KBアンフオライン・アクリルアミドゲルシートを用い
たエレクトロフォーカスインク◆こよる等電点は5.8
であり単一ピークを示し、7.5%ゲルデイスク電気泳
動では、ゲル中に入らないほど高分子でありSepha
rOse4B8を用いたゲル済過では約50万の分子量
を示した。又SDS電気泳動では分子量22,000の
単一バンドを示し、従つてこのものは通常の条件では分
子量22,000のサブユニツトの会合体で存在すると
考えられる。又、以下に記す実施例からも明らかなとお
り、本発明のレクチンのアミノ酸分析の結果では、Pr
O,Metおよび1/2Cysが見出されず、Tyrの
存在がごくわずかであり、従来から知られているアメリ
カ産カブトガニ由来のレクチンとは異なつれレクチンで
あることがわかる。又、ウマ赤血球に対する挙動の比較
からも、本発明のレクチンはアメリカ産カブトガニ由来
のレクチンとは明らかに異なつた新規なレクチンである
。本発明の日本産カブトガニレクチンは、グルコース(
GIc)、ガラクトース(Gal)、マンノース(Ma
n)、フコース(Fuc)等の中性糖、グルクロン酸の
ごとき糖酸、グルコサミン(GlcNH,)、ガラクト
サミン(GalNH2)等の糖アミンに対しては親和性
を示さなかつたが、N−アセチルノイラミン酸(NAN
A)、N−アセチルグルコサミン(GlcNAc)、N
−アセチルガラクトサミン(Ga一1NAc)及びN−
アセチルマノンサミン(ManNAc)等のN−アセチ
ルアミノ糖には強い親和性を示す。The present inventors discovered the presence of a new lectin in the hemolymph of a Japanese horseshoe crab, which has properties not found in the lectin derived from the North American horseshoe crab, and fractionated and purified this lectin. Namely, the Japanese horseshoe crab (Tachypleus
An agarose-based carrier for affinity chromatography, which uses the blood fluid of a cow, horse, sheep, etc., as a ligand, and N-acetylamino sugar-containing substances such as chitin. One fraction of NANAsN-acetylglucosamine (GlcNAc), N-acetylgalactosamine (Gl'NAc), and N-acetylmannosamine (M
The lectin is purified using an affinity chromatography carrier having N-acetylamino sugars as a binding ligand, such as anNAc), to obtain a lectin that shows affinity for these N-acetylamino sugars. The lectin of the present invention thus obtained is L
Electrofocus ink using KB Ampholine acrylamide gel sheet ◆Koyoru's isoelectric point is 5.8
It showed a single peak, and in 7.5% gel disk electrophoresis, it was so high that it did not enter the gel, and Sepha
Gel filtration using rOse4B8 showed a molecular weight of about 500,000. Furthermore, SDS electrophoresis showed a single band with a molecular weight of 22,000, and it is therefore considered that this substance exists as an aggregate of subunits with a molecular weight of 22,000 under normal conditions. Furthermore, as is clear from the examples described below, the results of amino acid analysis of the lectin of the present invention show that Pr
O, Met, and 1/2Cys were not found, and the presence of Tyr was very small, indicating that this lectin was different from the conventionally known lectin derived from the American horseshoe crab. Furthermore, from a comparison of its behavior with horse red blood cells, the lectin of the present invention is a novel lectin that is clearly different from the lectin derived from American horseshoe crabs. The Japanese horseshoe crab lectin of the present invention contains glucose (
GIc), galactose (Gal), mannose (Ma
n), neutral sugars such as fucose (Fuc), sugar acids such as glucuronic acid, and sugar amines such as glucosamine (GlcNH) and galactosamine (GalNH2), but N-acetylneu Laminic acid (NAN)
A), N-acetylglucosamine (GlcNAc), N
-Acetylgalactosamine (Ga-1NAc) and N-
It shows a strong affinity for N-acetylamino sugars such as acetylmanonesamine (ManNAc).
このN−アセチルアミノ糖類に対する特異的な親和性を
利用して、本発明レクチンを生体内におけるN−アセチ
ルアミノ糖類の分布及び役割を明らかにするための手段
として応用することができる。以下、実施例を挙げて本
発明をさらに詳しく説明する。Utilizing this specific affinity for N-acetylaminosaccharides, the lectin of the present invention can be applied as a means to clarify the distribution and role of N-acetylaminosaccharides in vivo. Hereinafter, the present invention will be explained in more detail with reference to Examples.
実施例 1
ウシ顎下腺ムチン(シグマ社試薬)500719をBr
CN活性化セフアロース4B(フアルマシア・フアイン
ケミカル社製)4007711に結合させ、NANA含
有のウシ顎下腺ムチンをリガントとするアフイニテイク
ロマトグラフイ一用カラムを作製する。Example 1 Bovine submandibular gland mucin (Sigma reagent) 500719 was added to Br
A column for Affinity chromatography is prepared by binding to CN-activated Sepharose 4B (manufactured by Pharmacia Fine Chemicals) 4007711 and using NANA-containing bovine submandibular gland mucin as a ligand.
このカラムを0.15MNac1、20mMcac12
を含有する0.05Mトリス−HCl緩衝液(PH7.
O)で充分洗浄した後、このカラムに、日本産カブトガ
ニの血リンパ液11を流し、ウシ顎下腺ムチン結合性物
質を吸着せしめる。このカラムを40,15MNaC1
含有0,1Mホウ酸緩衝液(PH8.5)、650mM
N−アセチルグルコサミン、0.15MNaC1、20
mMCaC12含有0.05Mトリス緩衝液(PH7.
O)、61MNaC1含有0.05Mトリス緩衝液(P
H7.O)の各溶媒を用いて順次溶出を行つた。この時
のクロマトグラムを図1に示し得られた画分の分析値を
第1表に示した。凝集活性の測定は、表示動物血球をマ
イクロタイタ一を用いて日本免疫学会編免疫実験操作法
(木村義民執筆、1971年)67ページの記載の方法
に準じて、2倍稀釈で行なつた。This column was 0.15M Nacl, 20mMcac12.
0.05M Tris-HCl buffer (pH 7.
After thorough washing with O), Japanese horseshoe crab hemolymph fluid 11 is poured into this column to adsorb bovine submandibular gland mucin-binding substances. This column was 40,15M NaCl
Contains 0.1M borate buffer (PH8.5), 650mM
N-acetylglucosamine, 0.15M NaCl, 20
0.05M Tris buffer containing mMCaC12 (PH7.
O), 0.05M Tris buffer containing 61M NaCl (P
H7. Elution was performed sequentially using each of the solvents listed above. The chromatogram at this time is shown in FIG. 1, and the analytical values of the obtained fractions are shown in Table 1. The agglutination activity was measured by diluting the indicated animal blood cells twice using a microtiter according to the method described in Immunology Experimental Procedures edited by the Japanese Society of Immunology (authored by Yoshitami Kimura, 1971), page 67.
凝集力価は凝集活性を示す最大稀釈値の逆数で示した。
実施例 21.39のN−アセチルガラクトサミンを公
知の方法に準じて市販エポキシ・アクチベーテツド・セ
フアロース6B(フアルマシア・フアインケミカル社製
)25Tn1に結合させN−アセチルガラクトサミンを
リガントとするアフイニテイクロマトグラフイ一用担体
を調製しカラムとする。The agglutination titer was expressed as the reciprocal of the maximum dilution value indicating agglutination activity.
Example 21. Affinity chromatography using N-acetylgalactosamine as a ligand was carried out by binding N-acetylgalactosamine of 39 to commercially available epoxy activated Sepharose 6B (manufactured by Pharmacia Fine Chemicals) 25Tn1 according to a known method. Prepare a single carrier and use it as a column.
実施例1で得たM3画分9.2ワ蛋白相当量をこのアフ
イニテイクロマトグラフイ一用カラムで処理し、目的の
レクチンを結合せしめる。An amount equivalent to 9.2% of the M3 fraction obtained in Example 1 was treated with this affinity chromatography column to bind the lectin of interest.
水洗後、N−アセチルマンノサミンO〜0.5Mの直線
濃度勾配法により溶出し第2図に示すクロマトグラムを
得た。N−アセチルマノンサミン溶出により、ヒトO型
赤血球に対する凝集活性は処理活性の80%が回収され
た。この活性画分をゲル済過により脱塩後凍結乾燥し、
日本産カブトガニレクチンを7.8W9得た。このレク
チンのアミノ酸分析(こよる構成アミノ酸分析結果をア
メリカ産カブトガニ由来のレクチンのアミノ酸組成と比
較して第2表に示す。After washing with water, elution was performed using a linear concentration gradient method using N-acetylmannosamine O to 0.5M to obtain the chromatogram shown in FIG. By N-acetylmanonesamine elution, 80% of the agglutination activity against human type O red blood cells was recovered. This active fraction was desalted by gel filtration and then lyophilized.
Japanese horseshoe crab lectin 7.8W9 was obtained. Amino acid analysis of this lectin (compared with the amino acid composition of lectin derived from American horseshoe crabs) is shown in Table 2.
本発明の日本産カブトガニレクチンのアミノ酸分析の結
果では、PrO.Met.l/2Cysが見出されずT
ryが非常に少なかつた。本発明のレクチンのヒトO型
赤血球凝集活性に対する各種単糖の阻害を第3表に示す
。The results of amino acid analysis of the Japanese horseshoe crab lectin of the present invention show that PrO. Met. l/2Cys was not found T
There were very few ry. Table 3 shows the inhibition of various monosaccharides on the human O-type hemagglutination activity of the lectin of the present invention.
本発明のレクチンのヒトO型赤血球凝集活性に対する各
種シアル酸含有糖ペプチツドの阻害を第4表に示す。Table 4 shows the inhibition of various sialic acid-containing glycopeptides on the human O-type hemagglutination activity of the lectin of the present invention.
糖ペプチツドの濃度は、シアル酸に換算した濃度で示す
。本発明のレクチンのヒトO型赤血球およびウマ赤血球
に対する凝集力価、および対応するそれぞれの赤血球を
ノイラミニダーゼ処理した後の凝集力価を第5表に示す
。Concentrations of glycopeptides are expressed in terms of sialic acid. Table 5 shows the agglutination titers of the lectin of the present invention against human type O red blood cells and horse red blood cells, and the corresponding agglutination titers after treating each red blood cell with neuraminidase.
第5表から明らかなようにヒトO型赤血球ではノイラミ
ニダーゼ処理により凝集力価は激減する。As is clear from Table 5, the agglutination titer of human type O red blood cells is drastically reduced by neuraminidase treatment.
しかしウマ赤血球では力価の低下は認められない。この
ことは、ヒトO型赤血球の場合本発明のレクチンとの凝
集にシアル酸が大きな役割をはたしていることが推定さ
れる。However, no decrease in titer was observed in horse red blood cells. This suggests that sialic acid plays a major role in the agglutination of human type O red blood cells with the lectin of the present invention.
第1図は、日本産カブトガニの血リンパ液のアフイニテ
イ一・クロマトグラムを示す。
A:0.15MNaC1含有0.1Mホウ酸緩衝液によ
る溶出開始点、B:50mMN−アセチルグルコサミン
、0.15MNaC1、20mMCaC12含有0.0
5Mトリス緩衝液による溶出開始点、C:1MNaC1
含有0.05Mトリス緩衝液による溶出開始点。
第2図は、実施例1で得られたM3画分のアフイニテイ
ークロマトグラム(N−アセチルマンノサミンO〜0.
5Mの直線濃度勾配法による。FIG. 1 shows an affinity chromatogram of the hemolymph of a Japanese horseshoe crab. A: Elution start point with 0.1M borate buffer containing 0.15M NaCl, B: 0.0 containing 50mM N-acetylglucosamine, 0.15M NaCl, 20mMCaC12
Elution start point with 5M Tris buffer, C: 1M NaCl
Elution start point with 0.05M Tris buffer containing. FIG. 2 shows the affinity chromatogram of the M3 fraction obtained in Example 1 (N-acetylmannosamine O~0.
By 5M linear concentration gradient method.
Claims (1)
カスインク)サブユニットの分子量:22,000 アミノ酸組成(モル%):Lys7.6 His4.5 Arg1.9 Asp(n)19.1 Thr6.7 Ser7.5 Glu(n)8.0 Pro0.0 Gly13.5 Ala4.9 1/2Cys0.0 Val5.9 Met0.0 Ile7.2 Leu8.2 Tyr0.4 Phe4.5 を有することを特徴とする日本産カブトガニTa−ch
ypleustridentatusより得られるN−
アセチルアミノ糖親和性レクチン。 2 日本産カブトガニ(Tachypleustrid
e−ntatus)の血リンパ液を出発物質としてN−
アセチルアミノ糖及び/またはN−アセチルアミノ糖含
有物質をリガンドとするアフイニテイクロマトグラフイ
ーを用いることを特徴とするN−アセチルアミノ糖親和
性レクチンの分離精製法。[Claims] 1. The following physicochemical properties: Isoelectric point: 5.8 (electrofocus ink using an acrylamide gel sheet) Molecular weight of subunit: 22,000 Amino acid composition (mol%): Lys7.6 His4 .5 Arg1.9 Asp(n)19.1 Thr6.7 Ser7.5 Glu(n)8.0 Pro0.0 Gly13.5 Ala4.9 1/2Cys0.0 Val5.9 Met0.0 Ile7.2 Leu8. Japanese horseshoe crab Ta-ch characterized by having 2 Tyr0.4 Phe4.5
N- obtained from ypleus tridentatus
Acetylaminosugar affinity lectin. 2 Japanese horseshoe crab (Tachypleustrid)
N-
1. A method for separating and purifying a lectin with affinity for N-acetylamino sugars, which comprises using affinity chromatography using acetylamino sugars and/or N-acetylamino sugar-containing substances as ligands.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP634077A JPS5945679B2 (en) | 1977-01-25 | 1977-01-25 | Captoganillectin and its isolation and purification method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP634077A JPS5945679B2 (en) | 1977-01-25 | 1977-01-25 | Captoganillectin and its isolation and purification method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5392800A JPS5392800A (en) | 1978-08-15 |
JPS5945679B2 true JPS5945679B2 (en) | 1984-11-07 |
Family
ID=11635624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP634077A Expired JPS5945679B2 (en) | 1977-01-25 | 1977-01-25 | Captoganillectin and its isolation and purification method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5945679B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5523395A (en) * | 1991-09-02 | 1996-06-04 | Maruha Corporation | Lectin species obtained from Japanese horseshoe crabs and from southern horseshoe crabs |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3402476B2 (en) * | 1992-08-24 | 2003-05-06 | 生化学工業株式会社 | Lipopolysaccharide binding protein and method for producing the same |
-
1977
- 1977-01-25 JP JP634077A patent/JPS5945679B2/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5523395A (en) * | 1991-09-02 | 1996-06-04 | Maruha Corporation | Lectin species obtained from Japanese horseshoe crabs and from southern horseshoe crabs |
Also Published As
Publication number | Publication date |
---|---|
JPS5392800A (en) | 1978-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jollès | [12] Lysozymes from rabbit spleen and dog spleen | |
Mason et al. | The influence of inorganic ions and acclimation salinity on hemocyanin-oxygen binding in the blue crab Callinectes sapidus | |
AU647734B2 (en) | Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections | |
US5760177A (en) | Lipopolysaccharide binding protein and process for producing the same | |
Kalbe et al. | Snail host finding by Fasciola hepatica and Trichobilharzia ocellata: compound analysis of “miracidia-attracting glycoproteins” | |
Shimizu et al. | Lectins in the hemolymph of Japanese horseshoe crab, Tachypleus tridentatus | |
Giga et al. | A new multimeric hemagglutinin from the coelomic fluid of the sea urchin Anthocidaris crassispina | |
Vasta et al. | Serological characterization of humoral lectins from the freshwater prawn Macrobrachiumrosenbergii | |
Sakakibara et al. | An anti-A-like lectin of Rana catesbiana eggs showing unusual reactivity | |
Müller et al. | Two different aggregation principles in reaggregation process of dissociated sponge cells (Geodia cydonium) | |
JPS5944286B2 (en) | Purification method of bovine thrombin | |
JPH01235852A (en) | Preparation of reagent | |
JPS5945679B2 (en) | Captoganillectin and its isolation and purification method | |
Basch et al. | Identification of the milk fat globule membrane proteins: I. Isolation and partial characterization of glycoprotein B | |
Barteling | A simple method for the preparation of agarose | |
Fock et al. | Isolation and characterisation of a serum lectin from blue gourami, Trichogaster trichopterus (Pallus) | |
e Castro et al. | Action of a thionin isolated from nuts of Pyrularia pubera on human erythrocytes | |
AU603411B2 (en) | Lectin and method for the extraction thereof from scallop | |
塩見一雄 et al. | Biochemical properties of hemagglutinins in the red alga Serraticardia maxima. | |
Myers et al. | Separation of glomerular basement membrane substances by sodium dodecylsulfate disc gel electrophoresis and gel filtration | |
Nishino et al. | Distribution of chitinolytic enzymes in the organs and cDNA cloning of chitinase isozymes from the liver of golden cuttlefish Sepia esculenta | |
JPS5927828A (en) | Preparation of amebocyte lysate | |
緒方京子 et al. | Studies on bioactive marine metabolites. VI. Isolation and characterization of Balanus balanoides agglutinin. | |
JPH02138193A (en) | Amebocyte lysate having high specificity to beta-glucans and production thereof | |
JPH04164100A (en) | Lectin of limulus polyphemus and method for separating and purifying the same |